Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183)
Clinical trial NCT02576977 · TERMINATED
Trial details
- NCT number
- NCT02576977
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-19
- Primary completion
- 2018-07-09
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.